Concepedia

A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma

Perrine Marec‐Bérard, Cécile Dalban, Nathalie Gaspar, Laurence Brugières, Jean‐Claude Gentet, Cyril Lervat, Nadège Corradini, Marie‐Pierre Castex, Claudine Schmitt, Hélène Pacquement,

European Journal of Cancer · 2019 · 29 citations · 25 references

DOI

Concepts

References

25

Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)

Beate Kempf‐Bielack, Stefan Bielack, Heribert Jürgens et al. · Journal of Clinical Oncology · 2005 · 648 citations

, , +9

Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Paolo G. Casali, Stefan Bielack, N. Abecassis et al. · Annals of Oncology · 2018 · 641 citations · Full text

, , +16

Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement.

Huvos Ag, Gerald Rosen, Marcove Rc · PubMed · 1977 · 401 citations

, , +14

Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial

Giovanni Grignani, Emanuela Palmerini, Virginia Ferraresi et al. · The Lancet Oncology · 2014 · 335 citations · Full text

, , +9

Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study

Florence Duffaud, Olivier Mir, Pascaline Boudou‐Rouquette et al. · The Lancet Oncology · 2018 · 316 citations

, , +13